Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

T-Lymphoblastic Lymphoma in a Patient with Pearson Syndrome Following Mitochondrial Augmentation

Elad Jacoby, Reut Fluss, Efrat Glick Saar, Shachar Naor, Ortal Barel, Niv Sabath, Noa Sher, Noa Greenberg-Kushnir, Bella Bielorai, Natalie Yivgi Ohana, Amos Toren, Gideon Rechavi

Blood (2024) 144 (Supplement 1): 2065.

https://doi.org/10.1182/blood-2024-199972

Published: 2024

Journal Articles

Epigenetic loss of m 1 A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome

Blood (2021) 137 (7): 994–999.

https://doi.org/10.1182/blood.2020005823

Published: 2021

Includes: Supplemental data

Journal Articles

Perturbation of fetal hematopoiesis in a mouse model of Down syndrome’s transient myeloproliferative disorder

Yehudit Birger, Liat Goldberg, Timothy M. Chlon, Benjamin Goldenson, Inna Muler, Ginette Schiby, Jasmin Jacob-Hirsch, Gideon Rechavi, John D. Crispino, Shai Izraeli

Blood (2013) 122 (6): 988–998.

https://doi.org/10.1182/blood-2012-10-460998

Published: 2013

Includes: Supplemental data

Journal Articles

Hematopoietic Size Control: A Novel Role for Factor VIII Via the Thrombin/PAR1 Axis in Regulating the Interplay Between Dynamic Bone Structure and Long Term Survival and Mobilization of Hematopoietic Stem Cells

Anna Aronovich, Yaniv Nur, Chava Rosen, Yael Klionsky, Liran Yarimi, David Hagin, Gideon Rechavi, MD, PhD, Uriel Martinowitz, Dalit Tchorsh–Yutsis, Yair Reisner

Blood (2011) 118 (21): 19.

https://doi.org/10.1182/blood.V118.21.19.19

Published: 2011

Journal Articles

Combining the Ras Inhibitor Salirasib and Proteasome Inhibitors: A Potential Treatment for Multiple Myeloma

Shira Yaari-Stark, Yael Nevo-Caspi, Jasmine Jacob-Hircsh, Gideon Rechavi, MD, PhD, Arnon Nagler, M.D., Yoel Kloog

Blood (2010) 116 (21): 1810.

https://doi.org/10.1182/blood.V116.21.1810.1810

Published: 2010

Journal Articles

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2 : a report from the International BFM Study Group

Blood (2010) 115 (5): 1006–1017.

https://doi.org/10.1182/blood-2009-08-235408

Published: 2010

Includes: Supplemental data

Journal Articles

MODELING and Targeting ERG -INDUCED Acute MYELOID LEUKEMIA (AML).

Gil Smooha, Yehudit Birger, PhD, Liat Goldberg, PhD, Jasmine Jacob-Hirsch, MSc, Ninette Amariglio, PhD, Gideon Rechavi, MD, PhD, Ditsa Levanon, PhD, Yoram Groner, PhD, Anat Taragan, Yoel Kloog, PhD, Jeremy Q Wen, PhD, MD, John Crispino, PhD, Michael D. Radmacher, Guido Marcucci, MD, Clara D. Bloomfield, MD, Shai Izraeli, MD

Blood (2009) 114 (22): 475.

https://doi.org/10.1182/blood.V114.22.475.475

Published: 2009

Journal Articles

DOWN'S Syndrome Acute Lymphoblastic LEUKEMIA: A HIGHLY Heterogeneous DISEASE DRIVEN by an Aberrant CRLF2/JAK2 Cooperation – A REPORT FROM the Ibfm-STUDY GROUP.

Blood (2009) 114 (22): 11.

https://doi.org/10.1182/blood.V114.22.11.11

Published: 2009

Journal Articles

Imatinib Mesylate Affects the Expression of Lipid Metabolism Genes in K562, a Chronic Myeloid Leukemia Cell Line

Osnat Ashur-Fabian, PhD, Adi Har-Zahav, BSc, Aviv Shaish, PhD, Ninette Amariglio, PhD, Dror Harats, MD, Gideon Rechavi, MD, PhD, Martin Ellis, MD

Blood (2008) 112 (11): 4238.

https://doi.org/10.1182/blood.V112.11.4238.4238

Published: 2008

Journal Articles

Somatic Expansion of the Frataxin Gene GAA Repeats in MDS Patients.

Drorit Merkel, MD, H. Joachim Deeg, Amos Simon, B.A., Ninette Amariglio, PhD, Arnon Nagler, M.D., Gideon Rechavi, MD, PhD

Blood (2008) 112 (11): 1642.

https://doi.org/10.1182/blood.V112.11.1642.1642

Published: 2008

Journal Articles

The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation.

Sigal Tavor, MD, Manny Eisenbach, Jasmine Jacob-Hirsch, Tammar Golan, PhD, Isabelle Petit, PhD, Katz Ben-Zion, PhD, Sigi Kay, PhD, Shoshana Baron, Ninette Amariglio, PhD, Varda Deutsch, PhD, Elizabeth Naparstek, MD, Gideon Rechavi, MD, PhD

Blood (2008) 112 (11): 1621.

https://doi.org/10.1182/blood.V112.11.1621.1621

Published: 2008

Journal Articles

A Novel Role for Factor VIII and Other Coagulation Factors in Organ Size Control

Anna Aronovich, Dalit Tchorsh, Elias Shezen, Chava Rosen, Yael Klionsky, Sivan Cohen, Orna Tal, Uri Martinovich, Helena Katchman, Smadar Eventov-Friedman, Ninette Amariglio, PhD, Jasmine Jacob-Hirsch, Gideon Rechavi, MD, PhD, Yair Reisner

Blood (2008) 112 (11): 592.

https://doi.org/10.1182/blood.V112.11.592.592

Published: 2008

Journal Articles

Transformation to Myelofibrosis and Blastic Transformation of PV Are Associated with Higher JAK2 Mutation Levels.

Maya Koren-Michowitz, MD, Ninette Amariglio, PhD, Joseph Landman, BA, Gideon Rechavi, MD, PhD, Elena Ribakovsky, MD, Yoram Cohen, MD, Arnon Nagler, MD, MSc

Blood (2007) 110 (11): 1555.

https://doi.org/10.1182/blood.V110.11.1555.1555

Published: 2007

Journal Articles

Expression of Genes Regulating Iron Metabolism in Hepatocyte Cell-Line HepG2 Induced by Sera from MDS Patients.

Laura Breda, MD, Hussam Ghoti, MD, Stefano Rivella, MD, Gideon Rechavi, MD, Ioav Cabantchik, MD, Eliezer A. Rachmilewitz, MD

Blood (2007) 110 (11): 4612.

https://doi.org/10.1182/blood.V110.11.4612.4612

Published: 2007

Journal Articles

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Sara Gardenghi, Maria F. Marongiu, Pedro Ramos, Ella Guy, Laura Breda, Amy Chadburn, YiFang Liu, Ninette Amariglio, Gideon Rechavi, Eliezer A. Rachmilewitz, William Breuer, Z. Ioav Cabantchik, Diedra M. Wrighting, Nancy C. Andrews, Maria de Sousa, Patricia J. Giardina, Robert W. Grady, Stefano Rivella

Blood (2007) 109 (11): 5027–5035.

https://doi.org/10.1182/blood-2006-09-048868

Published: 2007

Includes: Supplemental data

Journal Articles

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance

Ronen Loebstein, Ilana Dvoskin, Hillel Halkin, Manuela Vecsler, Aharon Lubetsky, Gideon Rechavi, Ninette Amariglio, Yoram Cohen, Gie Ken-Dror, Shlomo Almog, Eva Gak

Blood (2006) 109 (6): 2477–2480.

https://doi.org/10.1182/blood-2006-08-038984

Published: 2006

Journal Articles

Ineffective Erythropoiesis in β-Thalassemia Is Characterized by Increased Iron Absorption Mediated by down Regulation of Hepcidin and up Regulation of Ferroportin.

Sara Gardenghi, PhD, Maria Marongiu, Pedro Ramos, Ella Guy, Laura Breda, PhD, Amy Chadburn, MD, Yifang Liu, Gideon Rechavi, MD, Ninette Amariglio, PhD, E.A. Rachmilewitz, MD, Diedra Wrighting, PhD, Nancy C. Andrews, MD, Maria de Sousa, MD, Patricia Giardina, MD, Robert W. Grady, PhD, Stefano Rivella, PhD

Blood (2006) 108 (11): 1543.

https://doi.org/10.1182/blood.V108.11.1543.1543

Published: 2006

Journal Articles

Down Regulation of Hepcidin and Haemojuvelin Expression in the Hepatocyte Cell-Line HepG2 Induced by Thalassaemic Sera.

Orly Weizer-Stern, Konstantin Adamsky, PhD, Ninette Amariglio, PhD, Carina Levin, MD, Ariel Koren, MD, William Breuer, PhD, Eliezer Rachmilewitz, MD, Sara Gardenghi, Stefano Rivella, PhD, Yoav Cabantchik, PhD, Gideon Rechavi, MD, PhD

Blood (2006) 108 (11): 1556.

https://doi.org/10.1182/blood.V108.11.1556.1556

Published: 2006

Journal Articles

Inhibition of Elastase or SDF-1/CXCR4 Axis Promotes Differentiation of Human AML Cells.

Sigal Tavor, MD, Jasmine Jacob-Hirsch, MSc, Manny Eisenbach, MSc, Sigi Kay, PhD, Shoshana Baron, Ninette Amariglio, PhD, Elizabeth Naparstek, MD, Gideon Rechavi, MD, PhD

Blood (2006) 108 (11): 1891.

https://doi.org/10.1182/blood.V108.11.1891.1891

Published: 2006

Journal Articles

Towards Stopping Imatinib Therapy under the Umbrella of Interferone: Alpha-Interferone Improves Molecular Response in CML Patients with Imatinib Induced Complete Cytogenetic Remission: An Early Observation from a Study of Pegylated Interferone in the Set up of Minimal Residual Disease.

Izhar Hardan, MD, Ninette Amariglio, PhD, Luba Trakhtenbrot, PhD, Avichai Shimoni, MD, Maya Koren-Michowitz, MD, Gideon Rechavi, MD PhD, Arnon Nagler, MD

Blood (2006) 108 (11): 4788.

https://doi.org/10.1182/blood.V108.11.4788.4788

Published: 2006

NARROW

T-Lymphoblastic Lymphoma in a Patient with Pearson Syndrome Following Mitochondrial Augmentation

Epigenetic loss of m 1 A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome

Perturbation of fetal hematopoiesis in a mouse model of Down syndrome’s transient myeloproliferative disorder

Hematopoietic Size Control: A Novel Role for Factor VIII Via the Thrombin/PAR1 Axis in Regulating the Interplay Between Dynamic Bone Structure and Long Term Survival and Mobilization of Hematopoietic Stem Cells

Combining the Ras Inhibitor Salirasib and Proteasome Inhibitors: A Potential Treatment for Multiple Myeloma

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2 : a report from the International BFM Study Group

MODELING and Targeting ERG -INDUCED Acute MYELOID LEUKEMIA (AML).

DOWN'S Syndrome Acute Lymphoblastic LEUKEMIA: A HIGHLY Heterogeneous DISEASE DRIVEN by an Aberrant CRLF2/JAK2 Cooperation – A REPORT FROM the Ibfm-STUDY GROUP.

Imatinib Mesylate Affects the Expression of Lipid Metabolism Genes in K562, a Chronic Myeloid Leukemia Cell Line

Somatic Expansion of the Frataxin Gene GAA Repeats in MDS Patients.

The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation.

A Novel Role for Factor VIII and Other Coagulation Factors in Organ Size Control

Transformation to Myelofibrosis and Blastic Transformation of PV Are Associated with Higher JAK2 Mutation Levels.

Expression of Genes Regulating Iron Metabolism in Hepatocyte Cell-Line HepG2 Induced by Sera from MDS Patients.

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance

Ineffective Erythropoiesis in β-Thalassemia Is Characterized by Increased Iron Absorption Mediated by down Regulation of Hepcidin and up Regulation of Ferroportin.

Down Regulation of Hepcidin and Haemojuvelin Expression in the Hepatocyte Cell-Line HepG2 Induced by Thalassaemic Sera.

Inhibition of Elastase or SDF-1/CXCR4 Axis Promotes Differentiation of Human AML Cells.

Towards Stopping Imatinib Therapy under the Umbrella of Interferone: Alpha-Interferone Improves Molecular Response in CML Patients with Imatinib Induced Complete Cytogenetic Remission: An Early Observation from a Study of Pegylated Interferone in the Set up of Minimal Residual Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only